Stocksigma LogoStocksigma Logo

Mahamaya Lifesciences Schedules Board Meeting to Approve Half-Year Financial Results

Mahamaya Lifesciences Limited has scheduled a Board of Directors meeting on 13th Nov'26 to consider and approve the standalone and consolidated unaudited

Mahamaya Lifesciences Schedules Board Meeting to Approve Half-Year Financial Results

Mahamaya Lifesciences Ltd 路 Intimation 路 13 Nov 2026, 5:30 am

Mahamaya Lifesciences Schedules Board Meeting to Approve Half-Year Financial Results Mahamaya Lifesciences Limited has scheduled a Board of Directors meeting on 13th Nov'26 to consider and approve the standalone and consolidated unaudited financial results for the half year ended 30th Sep'26. In compliance with SEBI insider trading regulations, the trading window for dealing in the company's equity shares has been closed since 1st Oct'26 and will reopen on 16th Nov'26.

Original exchange filing (PDF)

More announcements from Mahamaya Lifesciences Ltd

All Mahamaya Lifesciences Ltd announcements